FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition having an inhibitory effect on SGLT2. This composition includes a compound of formula
and a pharmaceutically acceptable vehicle.
EFFECT: obtaining a pharmaceutical composition capable to inhibit sodium-dependent glucose transporters found in the intestines and kidneys of mammals and being of value for the treatment of diabetes mellitus and its micro- and macrovascular complications.
1 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2746132C1 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| METHODS FOR SGLT2 INHIBITOR OBTAINING AND APPLICATION | 2013 |
|
RU2643764C2 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR APPLICATION | 2003 |
|
RU2337916C2 |
| O-ARYLGLUCOSIDE INHIBITORS OF SGLT2 AND METHOD FOR THEIR USING | 2001 |
|
RU2269540C2 |
| C-ARYLGLUCOSIDE INHIBITORS OF SGLT-2 | 2000 |
|
RU2262507C2 |
| C-PHENYL-1-THIOGLUCITOLS | 2007 |
|
RU2434862C2 |
| C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| CONDENSED HETEROCYCLIC DERIVATIVES MEDICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2387663C2 |
